Meet Penumbra @ CIRSE 2023 Copenhagen, Denmark | 9 – 13 September, 2023     Firstline Management of ALI: Primary Endpoint Results from STRIDE 30-day Analysis, Economic Perspectives, Clinical Case Review with Computer-Aided Thrombectomy, and Results from INDIAN-UP Sunday, 10 September | 16:45 – 17:05 CET | Room 20       STRIDE Study Outcomes and an Economic Comparison of Treating ALI with CDT vs. Mechanical Aspiration Thrombectomy Dr. Rafiuddin (Raf) Patel John Radcliffe Hospital, United Kingdom Interim Results of the INDIAN-UP Trial and Acute Limb Ischemia Case Discussion Prof. Gianmarco de Donato Università di Siena, Italy       Add to Calendar     Innovations in the Treament of Pulmonary Embolism and Management of Deep Vein Thrombosis with Computer-Aided Thrombectomy: Clinical Study Advancements and Case Review Monday, 11 September | 13:00 – 14:00 CET | Auditorium 15       MODERATOR: Prof. Christoph Binkert Kantonsspital Winterthur, Switzerland Introduction to the Session The History of Aspiration Pulmonary Embolism - Primary Percutaneous Treatment of PE with Lightning™ 12 Intelligent Aspiration: Clinical Update and Experience Current Status of Pulmonary Embolism Management Prof. Stavros Konstantinides Universitätsmedizin Mainz, Germany Clinical Evidence: EXTRACT-PE, Interim STRIKE-PE Study Results and STORM-PE Utilizing Lightning 12 for Primary Percutaneous ?Treatment of Pulmonary Embolism Dr. John Moriarty UCLA, Los Angeles, USA DVT - Can Early Thrombus Removal Improve the Outcomes for DVT Patients? Current Status of DVT Management Iliofemoral DVT Case Discussions Dr. Kush Desai Northwestern University Feinberg School of Medicine. Chicago, United States Current Status of DVT Management Upper Limb DVT Case Discussions Prof. Gerry O'Sullivan University Hospital Galway, Ireland       Add to Calendar     Physician images used with permission. Consents on file at Penumbra, Inc. Product availability varies by country. Prior to use, please refer to the Instructions for Use (IFU) for complete product indications, contraindications, warnings, precautions, potential adverse events, and detailed instructions for use. Please click here for the complete IFU Risk Statements. Please contact your local Penumbra representative for more information. Copyright ©2023 Penumbra, Inc. All rights reserved. The Penumbra P logos and Lightning are registered trademarks or trademarks of Penumbra, Inc. in the USA and other countries. 24572, Rev. B 08/23 OUS